Login / Signup

IL-2 antibodies in type 1 diabetes and during IL-2 therapy.

Guillaume ChurlaudMichelle RosenzwajgPatrice CacoubDavid SaadounDominique Valteau-CouanetNathalie ChaputAlberto PuglieseDavid Klatzmann
Published in: Diabetologia (2018)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • insulin resistance
  • metabolic syndrome
  • cell therapy
  • replacement therapy